TomoTherapy Inc. (NASDAQ: TOMO) will be expanding into the Australian and New Zealand marketplace. The company signed a distributor agreement with Nucletron Pty. Ltd. and was awarded a contract by Queensland Health to supply the first TomoTherapy treatment system in Australia to Royal Brisbane & Women's Hospital.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Nucletron is TomoTherapy's exclusive distribution partner in Australia and New Zealand. Nucletron is well positioned in the market to meet the demand for TomoTherapy. TomoTherapy's relationship with Nucletron and first installation with Royal Brisbane Hospital will provide the company with increased exposure of the benefits of their radiation therapy solution to a large, new market.
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
